Malaria Drug Breakthrough: Resistance Resistance News
- * New Malaria Therapy: A new non-artemisinin based malaria therapy has been developed.
- In essence, the article highlights a promising new development in the fight against malaria, specifically addressing the growing problem of drug resistance.
Here’s a breakdown of the key data from the provided text:
* New Malaria Therapy: A new non-artemisinin based malaria therapy has been developed.
* importance: This therapy is critically important as it offers an alternative to artemisinin-based treatments, which are facing growing resistance.
* Expert Opinion (Olugbenga mokuolu): Professor Mokuolu,a Nigerian expert,emphasizes the value of having additional tools to combat malaria,especially in areas where artemisinin resistance is increasing.
* Presentation & Validation: Trial data was presented at the American Society of Tropical Medicine and Hygiene meeting. David Fidock, the society’s president and a WHO advisor, praised the innovative approach to fighting drug-resistant malaria.
* Discovery process: The compound was discovered through screening 2.3 million molecules at Novartis labs, in collaboration with several research institutions (Swiss Tropical and Public Health Institute, wellcome Trust, and Medicines for Malaria Venture).
* Source: The information is provided by SciDev.Net.
In essence, the article highlights a promising new development in the fight against malaria, specifically addressing the growing problem of drug resistance.